Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma
Edward R. Scheffer Cliff, Gemma Reynolds, Rakesh Popat, Benjamin W. Teh, Aaron S. Kesselheim, Ghulam Rehman Mohyuddin
Topics & Concepts
MedicineMultiple myelomaBispecific antibodyAntibodyOncologyInternal medicineDaratumumabImmunologyCancer researchMonoclonal antibodyBortezomibMultiple Myeloma Research and TreatmentsMonoclonal and Polyclonal Antibodies Researchvaccines and immunoinformatics approaches